Releases - RaySearch Laboratories

View:

2005

 

Found press releases

 

RaySearch Laboratories AB (publ) Interim Report January 1 – September 30, 2005

11/16/2005 2:00 AM EST
• Net sales for the period amounted to SEK 50.7 M (29.0)
• Profit after tax totaled SEK 21.0 M (10.1)
• Earnings per share after tax amounted to SEK 1.86 (0.96)
• Operating profit amounted to SEK 29.0 M (11.1)
• Cash flow from operating activities amounted to SEK 32.7 M (10.1)
Johan Löf, President and CEO of RaySearch Laboratories AB, comments on the first nine months of the year as follows:

“The...

Scanditronix-Wellhöfer and RaySearch sign Letter of Intent regarding quality ass...

11/7/2005 5:17 AM EST
RaySearch Laboratories AB announce that a letter of intent has been signed with Scanditronix-Wellhöfer to enter into a long-term development and license agreement regarding new products for quality assurance of IMRT. RaySearch is a world leader in treatment planning for IMRT and in advanced software applications for radiation therapy of cancer. Scanditronix-Wellhöfer is a world leader in advanced dosimetry and...

Disclosure notice

8/25/2005 8:16 AM EST
Stockholm, August 25, 2005
Johan Löf, Erik Hedlund, Anders Brahme, Carl Filip Bergendal and Anders Liander (”the Principal Owners”) divested 400,000 B shares in RaySearch Laboratories AB (publ) (”RaySearch”) on August 25, 2005. This corresponds to 0.8 % of the votes and 3.5 % of the capital in RaySearch. Accordingly, as of August 25, 2005 the Principal Owners hold shares corresponding to 79.1% of the votes and...

RaySearch Laboratories AB (publ) Interim Report, January 1 – June 30, 2005

8/24/2005 2:00 AM EST
• Net sales for the period amounted to SEK 33.7 M (20.5) • Profit after tax totaled SEK 14.2 M (5.7) • Earnings per share after tax amounted to SEK 1.25 (0.54) • Operating profit amounted to SEK 19.7 M (7.9) • Cash flow from operating activities amounted to SEK 15.4 M (2.7) Johan Löf, President and CEO of RaySearch Laboratories AB, comments on the first six months of the year as follows:

”No organizational connection between RaySearch and RayClinic”

6/28/2005 7:56 AM EST
It has come to the attention of RaySearch Laboratories AB (publ) (RaySearch) that the company RayClinic AB (publ) (RayClinic) recently has promoted, through advertisements in the media, a new issue of shares directed to the public. In view of the similarity of the names of the two companies and that both companies are active in one way or another in the field of radiation therapy for cancer, RaySearch wishes to make...

RaySearch Laboratories AB to be listed on Stockholm Stock Exchange’s Attract40

6/21/2005 4:38 AM EST
Effective July 1, 2005, RaySearch Laboratories will be listed in the Attract40 segment of the Stockholm Stock Exchange’s O List. RaySearch develops and sells software for radiation therapy of cancer. The company was listed on the O List of the Stockholm Stock Exchange in November 2003 and, during the past six months, the market interest in RaySearch has been so extensive that the company now qualifies to join the...

Annual General Meeting in RaySearch Laboratories AB (publ)

5/19/2005 1:17 PM EST
Among other matters, the following decisions were made at the Annual General Meeting in RaySearch Laboratories, held May 19, 2005.

Johan Löf, Erik Hedlund, Carl Filip Bergendal, Claes-Göran Fridh and Hans Wigzell were re-elected as members of the Board. Thomas Pousette was re-elected as deputy member.

The Annual General Meeting resolved that the fee to the Board members who do not receive salary from the company...

RaySearch Laboratories AB (publ) Interim Report, January 1 – March 31, 2005

5/19/2005 8:02 AM EST
•Net sales for the period amounted to SEK 13.1 M (10.1) •Profit after tax totaled SEK 4.5 M (3.5) •Earnings per share after tax amounted to SEK 0.40 (0.33) •Operating profit amounted to SEK 6.2 M (4.9) •Cash flow from operating activities amounted to SEK 6.7 M (3.2) For further information, contact: Johan Löf, President and CEO RaySearch Laboratories AB Telephone: 08-545 061 30  

Philips and RaySearch sign new letter of intent regarding adaptive radiation the...

5/18/2005 7:57 AM EST
RaySearch Laboratories AB (publ) announces that a letter of intent has been concluded with Royal Philips Electronics to sign a long-term development- and license agreement pertaining to new products within adaptive radiation therapy, which is considered to be the next technology leap within radiotherapy for cancer. RaySearch and Philips already conduct extensive research and development within the area. Through the...

RaySearch Laboratories AB (publ) Year End Report as at December 31, 2004

2/8/2005 2:05 AM EST
• Net sales amounted to SEK 39.5m (34.0) in 2004 • Net profit was SEK 12.9m (8.7). • Earnings per share after tax reached SEK 1.23 (0.83) • Operating profit totaled SEK 14.8m (12.9) • Investments in research and development increased by over 40 percent For more information, please contact: Johan Löf, CEO RaySearch Laboratories AB Phone: +46 (0)8-545 061 30  

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT